Qinggang Wang

Bristol-Myers Squibb

Qinggang Wang, Ph.D., is currently a scientific director in Chemical Process Development in Bristol-Myers Squibb Company. His work has been focused on CMC analytical supports for various projects within BMS portfolio, including small molecules, synthetic peptides and oligonucleotides. Qinggang is a member of ISPE PQLI Q2/Q14 team and Analytical Leadership Group of IQ Consortium.